The Future is Here: New Advances in FIP Treatment and Research

For decades, a diagnosis of feline infectious peritonitis (FIP) was one of the most heartbreaking words a cat lover could hear. Once considered almost universally fatal, FIP left veterinarians and rescuers with little more than supportive care and hope.

But today, that story is changing—dramatically.

From Fatal to Treatable: A Breakthrough Era

The biggest shift in FIP treatment has come from the development of antiviral medications—especially GS-441524, a drug that directly targets the virus responsible for FIP.

Clinical studies and real-world experience now show that a high percentage of cats treated with GS-441524 go into remission, with many returning to completely normal, healthy lives. 

Even more encouraging, recent veterinary guidance reports that over 85–90% of cats respond to antiviral treatment, a remarkable success rate for a disease once thought untreatable. 

A Major Milestone: Legal Access Expanding

One of the biggest challenges in the past was access. For years, FIP treatments existed in a legal gray area, forcing desperate families to seek unregulated sources.

That’s now changing.

• As of 2024–2026, compounded forms of GS-441524 have become legally available in the United States through veterinary pharmacies.  

• Veterinarians can now prescribe consistent, quality-controlled medication, improving safety and outcomes.

• Additional antivirals, such as molnupiravir, are becoming available, offering more options for complex or resistant cases.  

This shift is huge—it means treatment is no longer underground. It’s becoming part of mainstream veterinary medicine.

What Treatment Looks Like Today

Modern FIP treatment is far more structured and effective than ever before:

• Oral antiviral therapy (most commonly GS-441524) is now the preferred first-line treatment

• Typical treatment duration is around 12 weeks, though shorter courses are being studied

• Many cats show improvement within just 2–5 days of starting treatment  

For rescuers and fosters, this is life-changing—cats that once would have declined quickly are now eating, playing, and recovering within days.

New Research Directions

While current treatments are already saving lives, research continues to push forward:

1. Shorter Treatment Protocols

New studies suggest some cats may recover with shorter treatment durations (as little as 6 weeks) while maintaining similar success rates. 

2. Combination Therapies

Researchers are exploring combining antivirals (like GS-441524 with other drugs) to improve outcomes, especially in:

• Neurological FIP

• Relapse cases

• Hard-to-treat presentations

3. Improved Drug Access & Formulations

Ongoing work is focused on:

• Easier-to-administer oral medications

• More consistent dosing

• Wider global availability

4. Understanding Why Some Cats Relapse

While most cats recover, a small percentage may relapse. New research is helping veterinarians:

• Adjust dosing more precisely

• Tailor treatment based on disease type

• Improve long-term cure rates

What This Means for Rescue Work

For rescues like ours, these advances are nothing short of transformative.

• Cats once considered “untreatable” now have a real chance

• Fosters can take on FIP cases with hope instead of fear

• Adopters are no longer facing a guaranteed loss

Most importantly, it means more lives saved.

A Message of Hope

FIP is no longer a death sentence.

Thanks to science, advocacy, and the dedication of veterinarians and rescuers around the world, we are witnessing one of the most remarkable turnarounds in feline medicine.

There is still more to learn. There are still barriers to access in some areas. But the progress we’ve seen in just a few years is incredible.

And for every cat who now gets a second chance because of these treatments, that progress means everything.

Garlic City Kitty Rescue has successfully treated 5 cats with FIP. Four of them survived and are thriving, and one, unfortunately, had to be humanely euthanized after failing treatment three times. RIP sweet Pumpkin.